Joseph Eron, MD, division chief of infectious diseases, was part of an expert panel focused on specific information and educational needs of health care professionals involved in diagnosis and treatment of HIV. (Republished from the UNC Health Care and UNC School of Medicine Newsroom)
Contagion, the nation’s leading digital and print resource dedicated to providing up-to-date, disease-specific information to health care practitioners and specialists in the field of infectious diseases, presented its most recent “Peer Exchange” panel discussion, “HIV Screening, Prevention, and Treatment Advances.” The video welcomed several experts in the treatment and management of HIV who provide peer-to-peer dialogue, insights, opinions, and perspectives on current trends and available treatments for patients with HIV.
“More than 1 million people in the United States are living with HIV today,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of Contagion. “Our panel of experts comes together in this cutting-edge discussion to explain the importance of treating HIV at an early stage, review several HIV tests available, briefly discuss the importance of rapid initiation of therapy after diagnosis, and provide recommendations for laboratory monitoring in patients started on an antiretroviral therapy.”
This Contagion “Peer Exchange” panel features five distinguished experts: Joseph J. Eron Jr., MD, professor of medicine and division chief of infectious diseases at the UNC School of Medicine, as moderator; Eric S. Daar, MD, of the Harbor-UCLA Medical Center; Ian D. Frank, MD, of the Perelman School of Medicine of the University of Pennsylvania; W. David Hardy, MD, of the Johns Hopkins University School of Medicine; and Paul E. Sax, MD, of Brigham and Women’s Hospital.
The first segment of this “Peer Exchange” series delves into a discussion on screening and prevention of HIV. In the second segment, the experts provide a brief overview of the current HIV treatment landscape. The third segment focuses on additional considerations for therapy, such as the importance of adherence to treatment and care. In the final segment, our experts discuss upcoming treatment options that are exciting for the HIV community.
Eron is director of the clinical core at the UNC Center for AIDS Research and member of the UNC Institute for Global Health and Infectious Diseases. He is also the Vice Chair of the AIDS Clinical Trials Group (ACTG), the oldest and largest of the five HIV research networks funded by the NIH.
For more information and view the video series, click here.